Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David Chin Yee"'
Autor:
Ella H Leung, Daniel J Oh, Shannon E Alderson, Joshlynn Bracy, Mia McLeod, Litzi I Perez, Alexander Bottini, David Chin Yee, Krishna Mukkamala
Publikováno v:
Clinical Ophthalmology.
Ella H Leung, Daniel J Oh, Shannon E Alderson, Joshlynn Bracy, Mia McLeod, Litzi I Perez, Alexander Bottini, David Chin Yee, Krishna Mukkamala Georgia Retina, Atlanta, GA, USACorrespondence: Ella H Leung, 833 Campbell Hill St NW, Suite 300, Marietta,
Publikováno v:
British Journal of Ophthalmology. 100:914-917
Purpose To evaluate the relative efficacy of as needed versus treat and extend regimen for the treatment of neovascular age-related macular degeneration (AMD). Methods We conducted a systematic review of studies that evaluated the efficacy of as need
Publikováno v:
Trends in Molecular Medicine. 21:43-51
The central role of vascular endothelial growth factor (VEGF) signaling in regulating normal vascular development and pathological angiogenesis has been documented in multiple studies. Ocular anti-VEGF therapy is highly effective for treating a subse
Autor:
Himanshu Aggarwal, Paul Edwards, Xiaoxi Qiao, David Chin Yee, Hua Gao, Yue Li, Shareef Ahmed, Oscar Kuruvilla
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 30:823-830
To determine whether penetrating scleral or corneal injury can enhance intraocular penetration of systemic moxifloxacin, vancomycin, and ceftazidime.Thirty rabbits were divided into 3 groups for each antibiotic and then further subdivided to receive
Publikováno v:
Current Opinion in Ophthalmology. 25:508-512
Purpose of review To update the knowledge on the risk factors and treatment options for choroidal neovascular membrane due to ocular histoplasmosis and to provide a treatment algorithm. Recent findings Smoking has been shown to be a strong risk facto
Autor:
P. Kumar Rao, Victoria H. Yom, Cecilia S Lee, James B. Earl, Gregory P. Van Stavern, David Chin-Yee, Rajendra S. Apte, Mouhammed Abuattieh
Publikováno v:
Ophthalmology. 121:2502-2504.e1